- Home
- ALXO vs RGT Comparison
ALXO vs RGT Comparison
Compare ALXO & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- RGT
- Stock Information
- Founded
- ALXO 2015
- RGT 1986
- Country
- ALXO United States
- RGT United States
- Employees
- ALXO N/A
- RGT N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- RGT Trusts Except Educational Religious and Charitable
- Sector
- ALXO Health Care
- RGT Finance
- Exchange
- ALXO Nasdaq
- RGT Nasdaq
- Market Cap
- ALXO 81.1M
- RGT 72.5M
- IPO Year
- ALXO 2020
- RGT N/A
- Fundamental
- Price
- ALXO $1.41
- RGT $11.64
- Analyst Decision
- ALXO Strong Buy
- RGT
- Analyst Count
- ALXO 6
- RGT 0
- Target Price
- ALXO $14.20
- RGT N/A
- AVG Volume (30 Days)
- ALXO 886.3K
- RGT 22.4K
- Earning Date
- ALXO 11-07-2024
- RGT 01-01-0001
- Dividend Yield
- ALXO N/A
- RGT 1.43%
- EPS Growth
- ALXO N/A
- RGT N/A
- EPS
- ALXO N/A
- RGT 0.92
- Revenue
- ALXO N/A
- RGT N/A
- Revenue This Year
- ALXO N/A
- RGT N/A
- Revenue Next Year
- ALXO N/A
- RGT N/A
- P/E Ratio
- ALXO N/A
- RGT $11.42
- Revenue Growth
- ALXO N/A
- RGT N/A
- 52 Week Low
- ALXO $1.19
- RGT $7.84
- 52 Week High
- ALXO $17.83
- RGT $11.08
- Technical
- Relative Strength Index (RSI)
- ALXO 47.30
- RGT 54.24
- Support Level
- ALXO $1.19
- RGT $11.34
- Resistance Level
- ALXO $1.63
- RGT $11.87
- Average True Range (ATR)
- ALXO 0.11
- RGT 0.14
- MACD
- ALXO 0.01
- RGT -0.01
- Stochastic Oscillator
- ALXO 50.00
- RGT 60.85
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.